DOHAPHARMA CO., LTD.

dohapharma.com

Dohapharma Co., Ltd. is market leader in pharmaceutical sector of Viet Nam, specialized in marketing and sales of pharmaceutical products. We are a dynamic marketing and trading company specialized in the importing and distribution of pharmaceutical and biologicals products in Vietnam. Currently we are importing and distributing a wide range of pharmaceutical products from world-class producers. If you are planning to address the Vietnamese market for your products, we have the answer for you. With a good sales and marketing infrastructure in the entire Vietnam republic as well as private sector of GPs and pharmacies through out the country, we could frontend you for your products. Dohapharma helps our clients to expand market share in the Vietnamese pharmaceutical market. Our team has extensive experience working in different fields of the pharmaceutical industry. We have experience from different levels including top management, business development, Rx and OTC marketing & sales, regulatory affairs management and deep knowledge of the local market.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

WAREHOUSE OPTIMIZATION HELPED A PHARMA COMPANY TO INTEGRATE DATA FROM DISPARATE SOURCE WITHIN THE SUPPLY CHAIN

Businesswire | May 07, 2020

news image

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement which examines the role of warehouse optimization in the pharma industry. This success story offers comprehensive insights into how Quantzig helped a pharma company who was facing a multitude of warehouse optimization and distribution challenges that were further complicated by the nature of the drugs that the...

Read More

Business Insights

FSD PHARMA ANNOUNCES LAUNCH OF NEW CORPORATE WEBSITE

FSD Pharma Inc. | January 24, 2022

news image

FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company’s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. “We have strategically assembled a team of scient...

Read More

Pharma Tech

PALATIN ANNOUNCES INTENT TO EFFECT REVERSE STOCK SPLIT

Palatin Technologies, Inc. | August 20, 2022

news image

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced that it intends to effect a 1-for-25 reverse split of its issued and outstanding common stock. The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on August 30, 2022 and the Company's common stock is expected to begin trading on a split-adjusted basis when t...

Read More

Business Insights

INNOVENT AND GENFLEET ANNOUNCE EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR GFH925 (KRAS G12C INHIBITOR)

Innovent Biologics | September 02, 2021

news image

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and GenFleet Therapeutics (Shanghai) Inc., a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, today jointly announced that they have entered into an exclusive license agreement for the development and commercialization of GenFleet&...

Read More
news image

WAREHOUSE OPTIMIZATION HELPED A PHARMA COMPANY TO INTEGRATE DATA FROM DISPARATE SOURCE WITHIN THE SUPPLY CHAIN

Businesswire | May 07, 2020

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement which examines the role of warehouse optimization in the pharma industry. This success story offers comprehensive insights into how Quantzig helped a pharma company who was facing a multitude of warehouse optimization and distribution challenges that were further complicated by the nature of the drugs that the...

Read More
news image

Business Insights

FSD PHARMA ANNOUNCES LAUNCH OF NEW CORPORATE WEBSITE

FSD Pharma Inc. | January 24, 2022

FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company’s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. “We have strategically assembled a team of scient...

Read More
news image

Pharma Tech

PALATIN ANNOUNCES INTENT TO EFFECT REVERSE STOCK SPLIT

Palatin Technologies, Inc. | August 20, 2022

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced that it intends to effect a 1-for-25 reverse split of its issued and outstanding common stock. The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on August 30, 2022 and the Company's common stock is expected to begin trading on a split-adjusted basis when t...

Read More
news image

Business Insights

INNOVENT AND GENFLEET ANNOUNCE EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR GFH925 (KRAS G12C INHIBITOR)

Innovent Biologics | September 02, 2021

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and GenFleet Therapeutics (Shanghai) Inc., a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, today jointly announced that they have entered into an exclusive license agreement for the development and commercialization of GenFleet&...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us